This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Cascade Prodrug Inc., University of Oregon. Active years: 2011-2014.
Company Filing History:
Years Active: 2011-2014
Title: Paul B Westberg: Innovator in Pharmaceutical Sciences
Introduction
Paul B Westberg is a notable inventor based in San Mateo, CA (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the treatment of hyperproliferative diseases. With a total of 3 patents to his name, Westberg's work has the potential to impact the medical community significantly.
Latest Patents
Westberg's latest patents include innovative treatments that utilize vinca alkaloid N-oxide analogs. The first patent focuses on the treatment of hyperproliferative diseases with these compounds, which have shown activity in addressing such disorders. The invention also encompasses pharmaceutical compositions and methods for using vinca alkaloid and analog N-oxides, either alone or in combination with other active agents. Another significant patent involves Mannich base N-oxide drugs, which are disclosed as containing acidic N—H groups. This patent outlines pharmaceutical compositions that comprise a therapeutically effective amount of Mannich base N-oxides and methods for their use in conjunction with other treatments.
Career Highlights
Throughout his career, Westberg has worked with various organizations, including Cascade Prodrug Inc. and the University of Oregon. His experience in these institutions has allowed him to develop and refine his innovative ideas in pharmaceutical research.
Collaborations
Westberg has collaborated with notable individuals in his field, including John F W Keana and John G Curd. These partnerships have likely contributed to the advancement of his research and the successful development of his patents.
Conclusion
Paul B Westberg is a distinguished inventor whose work in pharmaceutical sciences has led to the development of innovative treatments for hyperproliferative diseases. His contributions are poised to make a lasting impact in the medical field.
